Article Information
History
- November 27, 2025.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- C. Dallaire-Théroux1,2,#,
- H.L. Denis1,
- R. Cottez1,3,
- C. Tremblay1,
- A. Provencher1,3,
- J. Valentin-Escalera1,3,
- M. Leclerc1,3,
- A. Loiselle1,
- M. Tournissac1,3,
- O. Potvin4,
- S. Belleville5,
- A. Gangloff6,
- F. Picard3,4,
- H. Zetterberg7,8,9,10,11,12,13,
- Consortium for the Early Identification of Alzheimer’s Disease – Quebec (CIMA-Q)* and
- F. Calon1,3,#
- 1Neurosciences Axis, Centre de recherche du CHU de Québec - Université Laval, Quebec City, QC, Canada
- 2Division of Neuroscience, Hôpital de l’Enfant-Jésus, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Quebec City, QC, Canada
- 3Faculty of Pharmacy, Université Laval, Quebec City, QC, Canada
- 4Quebec Heart and Lung Research Institute (IUCPQ), Quebec City, QC, Canada
- 5Research centre, Institut universitaire de gériatrie de Montréal, Montreal, QC, Canada
- 6Oncology research axis, Centre de recherche du CHU de Québec - Université Laval, Quebec City, QC, Canada
- 7Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy of the University of Gothenburg, Gothenburg, Sweden
- 8Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- 9Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
- 10Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- 11Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- 12UK Dementia Research Institute at UCL, London, UK
- 13Centre for Brain Research, Indian Institute of Science, Bangalore, India
- ↵#Corresponding authors: Corresponding to: Frédéric Calon, Ph.D. Centre de recherche du CHU de Québec – Université Laval 2705, Boulevard Laurier, Room T2-67 Quebec City, QC, G1V 4G2, Canada E-mail: Frederic.Calon{at}pha.ulaval.ca Caroline Dallaire-Théroux Centre de recherche du CHU de Québec - Université Laval 2705, boulevard Laurier Quebec City, QC, Canada G1V 4G2 Email: caroline.dallaire-theroux.1{at}ulaval.ca
Posted November 27, 2025.
Distinct alterations of adiponectin, FGF-21 and IGFBP-2 link dysmetabolism with cognitive decline across the Alzheimer’s disease spectrum
